semaglutide aion Your diabetic patient on develops NAION. Do you stop the drug?, The EMA ( European Medicines Agency) says yes — in June 2025 it labeled NAION a very rare side effect of semaglutide and Semaglutide and Nonarteritic Anterior Ischemic

Lpez-Jornet P., Camacho-Alonso F., and Leon-Espinosa, S

The FDA has sent warning letters to companies marketing them for anything but research

MC3R and MC5R activation contribute to energy homeostasis and exocrine gland function, respectively

The complexity of p53-mediated metabolic regulation in tumor suppression

Huang, G

Waring, And the data we have to date suggests that when the drugs are stopped, the effect of the drug also reverses when it comes to weight loss. However, the changes the researchers noted were related to gene expression, a process by which information encoded in a gene is turned into a function, such as turning protein production on and off. So, it is likely that it isnt permanent but more related to the impact of the drug, Dr